PDS Biotechnology Valuation
| PDSB Stock | USD 0.69 0.01 2.11% |
PDS Biotechnology is undervalued. PDS Biotechnology Corp holds a recent Real Value of $2.39 per share. The prevailing price of the company is $0.6852. Our model determines the value of PDS Biotechnology Corp from inspecting the company fundamentals such as Shares Outstanding of 54.72 M, return on equity of -2.22, and Return On Asset of -0.46 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PDS Biotechnology's valuation include:
Undervalued
Today
Please note that PDS Biotechnology's price fluctuation is very risky at this time. Calculation of the real value of PDS Biotechnology Corp is based on 3 months time horizon. Increasing PDS Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since PDS Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PDS Stock. However, PDS Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.69 | Real 2.39 | Target 7.5 | Hype 0.7 |
The real value of PDS Stock, also known as its intrinsic value, is the underlying worth of PDS Biotechnology Corp Company, which is reflected in its stock price. It is based on PDS Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PDS Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PDS Biotechnology Corp helps investors to forecast how PDS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PDS Biotechnology more accurately as focusing exclusively on PDS Biotechnology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PDS Biotechnology's intrinsic value based on its ongoing forecasts of PDS Biotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PDS Biotechnology's closest peers. If more than one evaluation category is relevant for PDS Biotechnology we suggest using both methods to arrive at a better estimate.
PDS Biotechnology Cash |
|
PDS Biotechnology Total Value Analysis
PDS Biotechnology Corp is at this time projected to have valuation of 30.12 M with market capitalization of 38.35 M, debt of 21.83 M, and cash on hands of 52.98 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PDS Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
30.12 M | 38.35 M | 21.83 M | 52.98 M |
PDS Biotechnology Asset Utilization
One of the ways to look at asset utilization of PDS is to check how much profit was generated for every dollar of assets it reports. PDS Biotechnology holds a negative application of assets of -0.46 pct., losing $0.004622 for each dollar of assets held by the company. Unsuccessful asset utilization implies the company is being less competent with each dollar of assets it holds. Put it differently, asset utilization of PDS Biotechnology Corp shows how unproductive it operates for each dollar spent on its assets.PDS Biotechnology Profitability Analysis
Based on the key profitability measurements obtained from PDS Biotechnology's financial statements, PDS Biotechnology Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess PDS Biotechnology's ability to earn profits and add value for shareholders.Net Loss | First Reported 2014-09-30 | Previous Quarter -9.4 M | Current Value -9 M | Quarterly Volatility 4.6 M |
For PDS Biotechnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PDS Biotechnology Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PDS Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PDS Biotechnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PDS Biotechnology over time as well as its relative position and ranking within its peers.
PDS Biotechnology Earnings per Share Projection vs Actual
By analyzing PDS Biotechnology's earnings estimates, investors can diagnose different trends across PDS Biotechnology's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for PDS Biotechnology Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.PDS Biotechnology Ownership Allocation
PDS Biotechnology owns a total of 54.72 Million outstanding shares. Roughly 86.83 pct. of PDS Biotechnology outstanding shares are held by general public with 2.7 % owned by insiders and only 10.48 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PDS Biotechnology Profitability Analysis
Net Loss for the year was (37.61 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PDS Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PDS Biotechnology and how it compares across the competition.
About PDS Biotechnology Valuation
The stock valuation mechanism determines PDS Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of PDS Biotechnology. We calculate exposure to PDS Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PDS Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -53.8 K | -56.5 K |
PDS Biotechnology Current Valuation Indicators
Valuation refers to the process of determining the present value of PDS Biotechnology Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PDS we look at many different elements of the entity such as PDS's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PDS Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PDS Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PDS Biotechnology's worth.Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |